Cargando…

Atrial fibrillation and frailty

Both the prevalence of atrial fibrillation (AF) and frailty are increasing with age, and they often occur simultaneously, leading them to become the central concerns in this aging society. The incidence of frailty in patients with AF is highly variable, ranging from 4.4% to 75.4%, depending on diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qi, Du, Xin, Ma, Chang-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051874/
https://www.ncbi.nlm.nih.gov/pubmed/32165883
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.02.007
_version_ 1783502751480676352
author Guo, Qi
Du, Xin
Ma, Chang-Sheng
author_facet Guo, Qi
Du, Xin
Ma, Chang-Sheng
author_sort Guo, Qi
collection PubMed
description Both the prevalence of atrial fibrillation (AF) and frailty are increasing with age, and they often occur simultaneously, leading them to become the central concerns in this aging society. The incidence of frailty in patients with AF is highly variable, ranging from 4.4% to 75.4%, depending on different evaluating instruments used. Moreover, the incidence of frailty among patients with AF is on the rise, which indicated that patients with AF are more prone to frailty compared to patients without AF. The relationship between AF and frailty is complicated. Frailty elevates the risk of stroke and mortality in AF patients and is also associated with longer hospitalizations. On the other hand, it may reduce the appropriate anticoagulation in AF patients. However, the evidence of the effects of frailty on anti-arrhythmic and interventional therapy in patients with AF is scarce. Frailty affects both the management and the prognosis of AF in the geriatric population. Vice versa, AF could worsen the frail state and may represent a marker of frailty. However, there are still questions need to be resolved, for example, the impact of frailty on the interventional therapy of patients with AF. Therefore, the geriatric assessment of frailty should be considered when planning individualized management of AF in older patients.
format Online
Article
Text
id pubmed-7051874
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Science Press
record_format MEDLINE/PubMed
spelling pubmed-70518742020-03-12 Atrial fibrillation and frailty Guo, Qi Du, Xin Ma, Chang-Sheng J Geriatr Cardiol Review Both the prevalence of atrial fibrillation (AF) and frailty are increasing with age, and they often occur simultaneously, leading them to become the central concerns in this aging society. The incidence of frailty in patients with AF is highly variable, ranging from 4.4% to 75.4%, depending on different evaluating instruments used. Moreover, the incidence of frailty among patients with AF is on the rise, which indicated that patients with AF are more prone to frailty compared to patients without AF. The relationship between AF and frailty is complicated. Frailty elevates the risk of stroke and mortality in AF patients and is also associated with longer hospitalizations. On the other hand, it may reduce the appropriate anticoagulation in AF patients. However, the evidence of the effects of frailty on anti-arrhythmic and interventional therapy in patients with AF is scarce. Frailty affects both the management and the prognosis of AF in the geriatric population. Vice versa, AF could worsen the frail state and may represent a marker of frailty. However, there are still questions need to be resolved, for example, the impact of frailty on the interventional therapy of patients with AF. Therefore, the geriatric assessment of frailty should be considered when planning individualized management of AF in older patients. Science Press 2020-02 /pmc/articles/PMC7051874/ /pubmed/32165883 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.02.007 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Review
Guo, Qi
Du, Xin
Ma, Chang-Sheng
Atrial fibrillation and frailty
title Atrial fibrillation and frailty
title_full Atrial fibrillation and frailty
title_fullStr Atrial fibrillation and frailty
title_full_unstemmed Atrial fibrillation and frailty
title_short Atrial fibrillation and frailty
title_sort atrial fibrillation and frailty
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051874/
https://www.ncbi.nlm.nih.gov/pubmed/32165883
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.02.007
work_keys_str_mv AT guoqi atrialfibrillationandfrailty
AT duxin atrialfibrillationandfrailty
AT machangsheng atrialfibrillationandfrailty